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Abstract Human ether a' go-go potassium channel 2 (hEAG2)
was cloned and its properties were compared with the previously
characterized isoform hEAG1. In the Xenopus oocyte expression
system the time course of activation was about four times slower
and the voltage required for half-maximal subunit activation
was about 10 mV greater for hEAG2 channels. However, its
voltage dependence was smaller and, therefore, hEAG2 channels
start to open at more negative voltages than hEAG1.
Coexpression of both isoforms and kinetic analysis of the
resulting currents indicated that they can form heteromeric
channel complexes in which the slow activation phenotype of
hEAG2 is dominant. Upon expression in mammalian cells,
quinidine blocked hEAG1 channels (IC50 1.4 WM) more potently
than hEAG2 channels (IC50 152 WM), thus providing a useful
tool for the functional distinction between hEAG1 and hEAG2
potassium channels. ß 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Mutations in the ether a' go-go gene (eag) in Drosophila
melanogaster increase neuronal excitability and cause repeti-
tive ¢ring of motoneurons [1]. Heterologous expression of eag
in Xenopus oocytes revealed typical properties of an out-
wardly rectifying, voltage-activated potassium channel [2].
Mammalian EAG channels have been cloned from rat,
mouse, bovine and human and were characterized in heterol-
ogous expression systems [3^6].
As a common feature of EAG channels, hyperpolarizing
prepulses slow down activation. This e¡ect becomes most
prominent in the presence of extracellular Mg2 [3,7]. A sec-
ond, distinctive phenotype is the current inhibition by Ca2/
calmodulin, binding to the C-terminal domain [8,9].
EAG currents were identi¢ed in various cancer cell lines
[10^12], leading to the hypothesis that EAG may have a
role in malignant transformation. Pardo and coworkers [13]
found that stable transfection of Chinese hamster ovary
(CHO) cells with rEAG increased the proliferation rate and
enhanced tumor formation in a mouse model. It was proposed
that reduction of the membrane resting potential, caused by
EAG, promotes cell cycle progression. Such hyperpolarizing
activity of EAG channels was recently described for di¡eren-
tiating human myoblasts. Human (h) EAG channels are tran-
siently expressed in these cells and hyperpolarize the mem-
brane to induce myoblast fusion [6,14].
EAG channels are strongly expressed in brain [3,6]. The
physiological function in the central nervous system, however,
remains to be elucidated. The recent cloning of a second iso-
form of EAG from rat (rEAG2) and its restricted expression
in brain and testes has drawn further attention on the role of
both isoforms in the central nervous system [15,16]. Unfortu-
nately, functional analysis of the channels in neuronal cells is
hampered by the lack of potent blockers. Both EAG1 and
EAG2 were found to be quite insensitive to typical potassium
channel blockers [3,15]. In addition, the identi¢cation of func-
tional di¡erences will be required to discriminate both iso-
forms and to address their speci¢c functions. Although a di-
rect quantitative comparison with rEAG1 in the same
expression system is still lacking, it was concluded that
rEAG2 channels have a lower threshold for activation [17].
Here we describe the cloning of the hEAG2 isoform and its
functional expression in Xenopus oocytes. We directly com-
pare gating properties as well as pharmacological character-
istics of hEAG2 and hEAG1 channels and describe practical
tools for the discrimination of both isoforms.
2. Materials and methods
2.1. Cloning of hEAG2 and construction of expression plasmids
hEAG2 (GenBank accession number AF418206) was cloned from a
human brain cDNA phage library (Clontech, Heidelberg, Germany)
using a PCR screening approach with primers based on a published
EST sequence (accession number U69185). The full-length open read-
ing frame was sequenced and inserted into the oocyte expression vec-
tor pGEM-HE [18] and the mammalian expression vector pcDNA3
(Invitrogen, Groningen, The Netherlands). Insertion of hEAG1 (ac-
cession number AJ001366) into the same vector was described previ-
ously [9]. mRNA was synthesized with the T7 mMESSAGE mMA-
CHINE kit (Ambion, Austin, TX, USA). Two point mutants of
hEAG1 (L322H and G440C) were generated in two-step PCR reac-
tions.
2.2. Functional expression in Xenopus oocytes
Stage V oocytes were obtained from Xenopus laevis after ice^water/
tricaine anesthesia. Cells were injected with 50 nl of mRNA (5^500 ng/
Wl). Currents were recorded at 20 þ 0.5‡C 1^4 days after injection.
Two-electrode voltage clamp was performed with a Turbo-TEC
10CD ampli¢er (NPI electronic, Tamm, Germany). The bath solution
contained (in mM): 115 NaCl, 2.5 KCl, 1.8 CaCl2, 10 HEPES, pH 7.2
(NaOH) plus the indicated concentration of MgCl2. Tail currents
were measured in 40K-Ringer solution (in mM): 75 NaCl, 40 KCl,
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1.8 CaCl2, 10 HEPES, pH 7.2 (NaOH). Experiment control was per-
formed with the Pulse+PulseFit software package (HEKA elektronik,
Lambrecht, Germany). Leak and capacitance currents were corrected
with a P/n method. Pooled data are represented as means þ S.E.M.
(n = number of independent experiments).
Current activation was analyzed with a kinetic model described
earlier [19]. It is assumed that each of the four individual subunits
of the channel can reside in three states: slow, fast, and activated.
Transitions between ‘slow’ and ‘fast’ occur slowly, characterized with
the time constant dslow. The probability to ¢nd a subunit in ‘slow’ is
Pslow. Transitions from ‘fast’ to ‘activated’ correspond to the rapid
activation of voltage-gated potassium channels. In this model they are
lumped by a single exponential activation phase with time constant
dfast. For simplicity the model further assumes that channels only can
undergo the fast transitions when all four subunits have performed
the ¢rst step. Mathematically this can be expressed as sum of simple
time courses distributed binomially:
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In the two-electrode voltage clamp the time resolution is not high
enough to faithfully resolve dfast. Thus, analysis of current traces in
response to voltage steps yields two relevant parameters: dslow and
Pslow. The voltage dependence of Pslow was ¢t with Boltzmann func-
tions:
PslowV  P3r1 e3V3Vh=k 2
with the half-maximal activation voltage Vh and a slope factor k that
characterizes the voltage dependence.
Channel activation, i.e. channel open probability Po, was described
with fourth order Boltzmann functions ¢tted to tail current data:
P0V  11 e3V3Vh=k4 3
2.3. Functional expression in mammalian cell lines
CHO cells were transfected using the superfect reagent (Qiagen,
Hilden, Germany). Borosilicate glass patch pipettes were ¢lled with
(in mM): 130 KCl, 2 MgCl2, 10 EGTA, 10 HEPES, pH 7.4 (KOH).
The bath solution contained (in mM): 145 NaCl, 5 KCl, 2 MgCl2, 2
CaCl2, 10 HEPES, pH 7.4 (NaOH). Currents were measured with an
EPC9 patch clamp (HEKA elektronik) in the whole-cell con¢guration
with access resistances below 5 M6. Series resistance was compen-
sated for 70^85%.
E¡ects of channel blockers were allowed to equilibrate by repetitive
pulsing phases of at least 5 min. Current block was analyzed by mea-
suring the current at the end of a 1-s depolarization to +50 mV. The
Fig. 1. Current^voltage relationships of hEAG1 and hEAG2 channels expressed in Xenopus oocytes. A: Activation time courses of hEAG1 (a)
and hEAG2 (b) in response to 2-s depolarizing pulses from a holding potential of 3100 mV. The extracellular solution contained 5 mM
Mg2. The superimposed curves indicate data ¢ts according to Eq. 1. B: dslow from ¢ts in A as a function of the test voltage (n = 6). Under
these conditions Pslow was 0.57 for both hEAG1 and hEAG2. The curves are single exponential ¢ts to estimate the voltage dependence: 40
mV/e-fold for hEAG1 and 59 mV/e-fold for hEAG2. C: In 40K-Ringer solution 2-s depolarizations were applied and peak inward tail current
amplitudes were measured at 3100 mV. These were normalized to the value at 0 mV and plotted versus the test voltage on a semi-logarithmic
(upper panel) and linear scale (below) (n = 6). In the upper panel symbols are connected by straight lines. The continuous curves in the linear
plot are ¢ts to Eq. 3 yielding Vh and k that are shown in D as box plots.
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concentration dependence of block was described with a Hill equa-
tion:
I
Icontr
c 
IC50
c
 h
1 IC50
c
 h 4
with the Hill coe⁄cient h.
3. Results and discussion
3.1. Voltage dependence and kinetics of channel activation
The hEAG2 potassium channel was cloned from a cDNA
library. The derived amino acid sequence displays 73% identity
with hEAG1, exhibiting the highest divergence between the
cytoplasmic C-termini [6]. 98% identical residues are shared
between hEAG2 and the orthologue protein from rat,
rEAG2 [15]. For direct comparison of the hEAG isoforms,
we expressed both channels in Xenopus oocytes and measured
currents with a two-electrode voltage clamp. Despite identical
expression vector constructs, mRNA for hEAG2 consistently
yielded lower current amplitudes compared to hEAG1. Equal
current levels were obtained by about 20-fold higher dilution of
hEAG1 mRNA. Channel activation was assayed by depolariz-
ing voltage steps (Fig. 1A). In the presence of 5 mM Mg2,
both channel types generated slowly activating currents with-
out inactivation. The kinetics of channel activation were ana-
lyzed by ¢tting the EAG activation model (Eq. 1) to the data
(see methods). The resulting values for dslow are plotted in Fig.
1B as a function of the test voltage. It is clearly seen that
hEAG2 channels activate more slowly, at +40 mV by a factor
of about 4. The voltage dependence of the activation time
constants was weaker for hEAG2 than for hEAG1 (Fig. 1B).
Inward tail current amplitudes were measured in Mg2-free
40K-Ringer to assay steady-state activation (Fig. 1C). hEAG2
channels activate at lower voltages than hEAG1 channels. At
380 mV hEAG2 current already reached 4.5% of the current
at 0 mV, compared to 1.1% for hEAG1. The current^voltage
relationships were ¢tted according to Eq. 3 and the resulting
Vh and k values are shown in Fig. 1D. The half-activation
voltage of hEAG2 subunits (330.9 mV) was greater than for
hEAG1 subunits (Vh 343.3 mV). However, the slope factor k
for hEAG2 (median 45.6 mV) was consistently greater than
that for hEAG1 (median 23.6 mV), resulting in a lower acti-
vation threshold for hEAG2 channels.
In accordance with the early activation of both channel
types, we consistently observed resting potentials below 370
mV in 2.5 mM extracellular K solution when oocytes ex-
pressed either of the hEAG isoforms. In comparison, oocytes
expressing hKv1.5 potassium channels with similar current
amplitudes (10^20 WA at +40 mV) had resting potentials of
about 340 mV. The stronger hyperpolarizing activity of EAG
channels in oocytes suggests an impact on neuronal resting
potentials and excitability.
Fig. 2. Prepulse dependence of hEAG activation. A: Current traces of hEAG1 and hEAG2 channels, expressed in Xenopus oocytes with the in-
dicated concentrations of Mg2 in the bath solution. The pulse protocol was a depolarization to +40 mV preceded by 5-s intervals at prepulse
voltages ranging from 3140 to 330 mV. The superimposed curves (black) are results of data ¢ts according to Eq. 1. B: Pslow derived from
data ¢ts as shown in A for hEAG1 (open symbols) and hEAG2 (¢lled symbols) (n = 3) for 0.5 (squares), 2.0 (triangles), and 5.0 mM Mg2
(circles). The curves are ¢t results according to ¢rst- order Boltzmann functions Eq. 2. The resulting half-maximal voltage, Vh, and slope factor,
k, are plotted in C and D as a function of the Mg2 concentration.
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3.2. Prepulse dependence of channel activation
A typical feature of EAG channels is the dependence of
activation kinetics on the holding potential and the concen-
tration of extracellular Mg2 [7]. We measured channel acti-
vation in 0.5, 2, and 5 mM Mg2 under variation of the
prepulse voltage. Fig. 2A shows current traces for experiments
with hEAG1 and hEAG2 with superimposed ¢ts according to
Eq. 1. The values for Pslow as a function of the conditioning
voltage are shown in Fig. 2B, clearly indicating that hEAG2
channels do reach a smaller limiting Pslow at very negative
voltages. However, the voltage dependence of Pslow in
hEAG2 is smaller, leading to a cross-over of the curves.
Thus, at neuronal resting potentials, i.e. around 380 mV,
the probability for slow activation of hEAG2 subunits is high-
er than for hEAG1 subunits. The observation was quanti¢ed
by Boltzmann ¢ts yielding half-maximal voltages and slope
factors shown in Fig. 2C,D. At physiological Mg2 concen-
trations (2 mM) the half-maximal voltage for slow activation
of hEAG2 channels is 380 mV compared to 3107 mV for
hEAG1 channels.
This analysis revealed functional di¡erences between both
channels: the main characteristics of hEAG2 are a slower
activation time course and a smaller voltage dependence,
which is seen for steady-state activation (Fig. 1D) as well as
in the Pslow^V relation (Fig. 2B). The molecular background
for this di¡erence is not yet clear, as all residues in the voltage
sensor domains (S4) of both isoforms are conserved.
3.3. Coassembly of hEAG1 and hEAG2 subunits
Both isoforms of rEAG channels share some regions of
similarly high expression, e.g. cerebral cortex, amygdala and
olfactory bulb [16,17]. Thus, it is important to know whether
they can form heteromeric channels with intermediate pheno-
types. We coinjected mRNA for hEAG1 and hEAG2 at var-
ious ratios and analyzed the activation kinetics and the volt-
age dependence of Pslow. The resulting currents were
compatible with a mixing of hEAG1 and hEAG2 subunits
(not shown), but homomeric channels could not safely be
excluded. For an unambiguous analysis we enhanced the ki-
netic di¡erences between the subunits, using a point mutation
in the S3^S4 linker region of hEAG1 (L322H) leading to
faster activation [19]. Current traces for individual channels
and coinjections of hEAG1WL322H and hEAG2 are shown in
Fig. 3A. Mutant hEAG1 channels showed fast activation in
the presence of 5 mM Mg2, while hEAG2 currents had the
typical sigmoidal rising phase. Currents in coinjected oocytes
could not be explained as the sum of both individual time
courses (dotted line), suggesting heteromeric channel forma-
tion. Further evidence for heteromeric assembly came from a
dominant negative mutant of hEAG1 (mutation G440C in the
selectivity ¢lter) that did not yield current in Xenopus oocytes.
However, coexpression of hEAG1WG440C with either hEAG1
Fig. 3. Coassembly of hEAG1 and hEAG2 subunits. A: The rapidly
activating mutant hEAG1WL322H, wild-type hEAG2 channels and a
mixture of both were expressed in oocytes. Test pulses to +40 mV
were elicited after 5-s hyperpolarization to 3130 mV in bath solu-
tion with 5 mM Mg2. Average currents from six oocytes of each
group were normalized and superimposed. Currents from coinjected
cells show intermediate kinetics, which cannot be described as a
sum of fast and slow traces (dotted line). B: mRNA for hEAG1,
hEAG2 and hKv1.5 channels was injected into Xenopus oocytes in
concentrations leading to equal current amplitudes. In parallel injec-
tions the same mRNAs were coinjected with a dominant negative
mutant of hEAG1 (G440C). Averaged current traces from 40-mV
test pulses are shown for the absence (black) and presence (gray) of
the mutant. The bar graphs show the normalized amplitudes in
comparison to mean amplitudes of coinjections. n = 13^15.
Fig. 4. Block of hEAG channels in mammalian cells. A: Current
traces in response to depolarizations to +50 mV from a holding
voltage of 3100 mV from hEAG1 (left) and hEAG2 (right) chan-
nels expressed in CHO cells under control conditions and after ap-
plication of the indicated concentrations of quinidine. B: Dose^re-
sponse plots of hEAG1 (open circles) and hEAG2 (¢lled circles) for
quinidine (n = 4^6). The curves indicate ¢ts according to Eq. 4. Also
included are responses to 10 mM TEA (squares, n = 4 or 5) and
1 mM BaCl2 (triangles, n = 5) for hEAG1 (open symbols) and
hEAG2 (¢lled symbols).
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or hEAG2 resulted in a reduction of current (Fig. 3B). Coex-
pression with the non-related hKv1.5 channel did not signi¢-
cantly reduce the current.
We conclude that both hEAG isoforms interact and form
heteromeric channels. EAG heteromultimer formation could
thereby increase the functional variability of EAG currents in
regions of overlapping expression. The same was proposed for
the related ERG channels, which formed heteromers in vitro,
but did not interact with rEAG1 [20].
3.4. Pharmacological di¡erences between hEAG1 and
hEAG2 channels
EAG channels have been described as channels with low
sensitivity to classical channel blockers like tetraethylammo-
nium (TEA) or 4-amino-pyridine or the HERG blocker E4031
[15,21]. We chose mammalian cells for a pharmacological
characterization, to allow direct comparison to native cur-
rents. TEA, applied at 10 mM, only blocked the channels
by about 10% at +50 mV without signi¢cant di¡erence be-
tween hEAG1 and hEAG2 (P = 0.76, two-sided t-test). Ba2
ions extracellularly applied at a concentration of 1 mM inhib-
ited hEAG1 channels to 24 þ 8% of the control current, while
hEAG2 currents were only reduced to 71 þ 7% (n = 5,
P = 0.025). Quinidine, however, blocked hEAG1 with an
IC50 value of 1.4 þ 0.06 WM. In contrast, hEAG2 channels
were about 100-fold less sensitive (IC50 151.8 þ 24.8 WM)
(Fig. 4). Thus, quinidine can be used as a blocker of
hEAG1 channels in mammalian cells. In oocytes, a much low-
er sensitivity has been reported for rEAG1 (IC50 400 WM),
underlining the value of mammalian expression systems for
pharmacological studies [3].
In summary, the slower activation, the lower voltage depen-
dence and signi¢cantly lower quinidine sensitivity of hEAG2
channels provide tools to discriminate both isoforms of EAG
channels in neurons and cancer cells.
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